drugset / Trial / NCT00505284

An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy

NCT00505284

Phase 2/3 Completed 352 enrolled Eisai Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the efficacy and safety of Perampanel in patients with painful diabetic neuropathy.

Timeline

Start
2007-06
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Perampanel Small molecule 2 mg Oral
Comparator Perampanel Small molecule 4 mg Oral
Comparator Perampanel Small molecule 6 mg Oral
Comparator Perampanel Small molecule 8 mg Oral

Indications